enkephalin-met, arg(6)-phe(7)- has been researched along with naltrindole benzofuran in 1 studies
Studies (enkephalin-met, arg(6)-phe(7)-) | Trials (enkephalin-met, arg(6)-phe(7)-) | Recent Studies (post-2010) (enkephalin-met, arg(6)-phe(7)-) | Studies (naltrindole benzofuran) | Trials (naltrindole benzofuran) | Recent Studies (post-2010) (naltrindole benzofuran) |
---|---|---|---|---|---|
189 | 1 | 10 | 102 | 0 | 16 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Caffrey, JL; Farias, M; Jackson, KE; Yoshishige, D | 1 |
1 other study(ies) available for enkephalin-met, arg(6)-phe(7)- and naltrindole benzofuran
Article | Year |
---|---|
Cardiac enkephalins interrupt vagal bradycardia via delta 2-opioid receptors in sinoatrial node.
Topics: Analgesics; Analgesics, Opioid; Animals; Benzylidene Compounds; Bradycardia; Dogs; Enkephalin, D-Penicillamine (2,5)-; Enkephalin, Methionine; Naltrexone; Narcotic Antagonists; Oligopeptides; Opioid Peptides; Quinolines; Receptors, Opioid, delta; Sinoatrial Node; Vagus Nerve | 2003 |